๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Cipla's Pithampur facility received an OAI in August and a warning letter in February, but it is unlikely to escalate to import alerts.
โ€ข Top picks in largecaps are Sun Pharma and Cipla, while in midcaps, Torrent Pharma and JB Chemicals are preferred.
โ€ข The US and India markets are stabilizing for generics, and companies with strong compliance records are benefiting from drug shortages.